PREVALITE Drug Patent Profile
✉ Email this page to a colleague
When do Prevalite patents expire, and what generic alternatives are available?
Prevalite is a drug marketed by Upsher Smith Labs and is included in one NDA.
The generic ingredient in PREVALITE is cholestyramine. There are eight drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Prevalite
A generic version of PREVALITE was approved as cholestyramine by EPIC PHARMA LLC on August 15th, 1996.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PREVALITE?
- What are the global sales for PREVALITE?
- What is Average Wholesale Price for PREVALITE?
Summary for PREVALITE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for PREVALITE |
| DailyMed Link: | PREVALITE at DailyMed |
Pharmacology for PREVALITE
| Drug Class | Bile Acid Sequestrant |
| Mechanism of Action | Bile-acid Binding Activity |
US Patents and Regulatory Information for PREVALITE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Upsher Smith Labs | PREVALITE | cholestyramine | POWDER;ORAL | 073263-001 | Feb 22, 1996 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Upsher Smith Labs | PREVALITE | cholestyramine | POWDER;ORAL | 073263-002 | Oct 30, 1997 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
